Article
Regulatory T cell therapy for Graft-versus-Host Disease
16 Apr 2025
Abstract excerpt
Graft-versus-Host Disease (GvHD) is the main cause of morbidity and mortality of allogeneic hematopoietic cell transplantation (allo-HCT). Conventional immunosuppressive pharmacotherapy remains the backbone of GvHD prevention and treatment with suboptimal outcomes especially for patients with refractory disease. Adoptive immunotherapy with regulatory T-cells (Treg) stands as an alternative approach that aims to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
